Partial reprogramming strategies, whether they use OSK or chemical mimics like the 7c cocktail, keep hitting the same wall: the "rejuvenation gap." Even when we see functional improvements and lifespan extensions of 109% [https://www.liebertpub.com/doi/10.1089/cell.2023.0072], cells don't fully shed their "aging memory" in DNA methylation (DNAm) patterns [https://doi.org/10.1111/acel.12877]. This stubbornness is usually blamed on TET-mediated active DNA demethylation failing to reach specific, recalcitrant CpG sites [https://pmc.ncbi.nlm.nih.gov/articles/PMC10373966/].

It’s likely that this resistance isn't an inherent property of the sites themselves, but rather a result of kinetic competition. Exogenous reprogramming factors are essentially racing against endogenous maintenance methyltransferases like DNMT1. Recent Gladstone research highlights that newly replicated DNA is briefly hyperaccessible right after replication [https://gladstone.org/news/gladstones-scientific-highlights-2025]. In standard asynchronous protocols, OSK and TET enzymes encounter chromatin at various stages of compaction. I suspect the "recalcitrant" marks seen in iPSCs [https://doi.org/10.1111/acel.12877] are tucked away in late-replicating heterochromatin. In these regions, the window between DNA synthesis and the return of repressive architecture is simply too narrow for stochastic TET encounters to erase the marks before DNMT1 restores the aged state.

The key to complete epigenetic rejuvenation might be synchronizing factor activity with the S-phase. If we target TET2 catalytic activity to the post-replication fork—during that hyperaccessibility window—we can likely erase CpG marks that G1 and G2 phases usually shield through high-order folding. This would explain why 7c cocktails induce epigenetic states distinct from OSK [https://elifesciences.org/articles/90579]; while chemical hypomethylators act globally, they lack the targeted recruitment to newly synthesized strands that transcription factor-driven TET recruitment offers.

This hypothesis is easy to test:

1. Group A (Asynchronous): Standard OSK delivery via AAV or lentivirus.
2. Group B (Synchronized): Cells synchronized via double-thymidine block, with OSK/TET2 expression pulsed (using a Tet-On system) specifically during the S-phase to G2 transition.
3. Analysis: Single-cell methylome sequencing of the "recalcitrant" CpG islands [https://doi.org/10.1111/acel.12877].

If Group B shows a clearer reduction in aging markers than Group A, despite identical total factor exposure, it confirms the barrier is temporal and structural rather than purely biochemical. This would also help us determine if we can decouple the reduction in transcriptomic mortality age [https://doi.org/10.1101/2024.07.04.601982] from a loss of cellular identity—essentially erasing the noise without forcing the cell back to a pluripotent state.